|
|
354 Eisenhower Parkway, Second Floor, Plaza Floor Livingston, NJ 07039 USA phone:(866)566-5636 fax:(866)994-3001
|
|
| Symbol |
CBRX |
| Exchange |
NASDAQ |
| Founded |
0 |
| Employees |
|
|
|
| www.columbialabs.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Pharmaceuticals for women's health. |
 |
| Management |
| Michael McGrane, Senior Vice President, General Counsel and Secretary; George W. Creasy , Vice President, Clinical Research and Development; Robert S. Mills , President and Chief Executive; Officer Carl Worrell , Head of Sales and Marketing; Lawrence A. Gyenes, Senior Vice President, Chief Financial Officer and Treasurer |
| |
|
|
|
|
|
|
| |
|
|
|
|
| Keywords |
| bioadhesive, carbomer, metabolized, moisture, enzymes |
|
|
|
|
|
|
| Description |
|
It mission is to build a specialty women's healthcare business with a competitive advantage in the United States. We promote four prescription pharmaceutical products in the U.S., including CRINONE 8%...
view more
|
 |
| Technology / Differentiation |
| Columbia delivers these products primarily through its patented, proprietary Bioadhesive Delivery System (BDS), that uses bioadhesion to administer medication to patients in a targeted fashion over 12 to 72 hours. This technology can deliver hormones and other difficult-to-deliver compounds. This innovative technology differentiates Columbia from its competitors and provides a platform for numerous additional applications in the future. |
 |
 |
|
|
|
|
|
|